Doctor profile · Federal record
Dr. John Scagnelli, M.D.
Neurology Physician (CMS: Neurology) · Raleigh, NC
- NPI 1437268265
- Accepts Medicare
- MIPS 87.2 / 100 · 2023
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1540 Sunday Dr
Raleigh, NC 276076010
(919) 782-3456
fax (919) 783-1441
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- April 1, 2021
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- North Carolina #2012-00941
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437268265. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
45,529
Distinct HCPCS
10
Medicare allowed
$1,052,011
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2323 |
Injection, natalizumab, 1 mg | 17,100 | 22 | $23 | |
J2350 |
Injection, ocrelizumab, 1 mg | 12,900 | 18 | $24 | |
A9585 |
Injection, gadobutrol, 0.1 ml | 9,610 | 93 | $0 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 4,500 | 16 | $48 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 367 | 32 | $5 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 206 | 162 | $118 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 167 | 167 | $160 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 107 | 86 | $161 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 105 | 44 | $59 | |
70553 |
Mri scan of brain before and after contrast | 99 | 95 | $195 |
In context: peer comparison
Among 17 peers in Raleigh Neurology Physician, average services per provider: 1,155. This provider delivers 39× the peer median.Open Payments
Industry payments received
All-time total
$57,406
Transactions
273
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Tg Therapeutics, INC. | 43 | $25,801.77 | |
| Biogen, INC. | 15 | $11,551.10 | |
| Genentech USA, INC. | 17 | $8,827.13 | |
| Amgen INC. | 15 | $7,177.40 | |
| Alexion Pharmaceuticals, INC. | 20 | $687.66 | |
| Emd Serono, INC. | 25 | $469.94 | |
| Celgene Corporation | 36 | $406.74 | |
| Novartis Pharmaceuticals Corporation | 22 | $333.79 | |
| Mallinckrodt Hospital Products INC. | 20 | $229.13 | |
| Abbvie INC. | 13 | $223.94 | |
| Lilly USA, LLC | 15 | $205.25 | |
| Ucb, INC. | 9 | $192.02 | |
| Ani Pharmaceuticals, INC. | 6 | $171.97 | |
| Csl Behring | 9 | $151.90 | |
| Pfizer INC. | 8 | $141.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,068
Patients
505
Total drug cost
$163,271
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 338 | 83 | $8,395 |
| Donepezil Hcl | Generic | 302 | 83 | $3,523 |
| Baclofen | Generic | 227 | 62 | $9,533 |
| Dalfampridine ER (Dalfampridine) | Brand | 159 | 28 | $102,226 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 149 | 30 | $3,276 |
| Pregabalin | Generic | 124 | 28 | $4,727 |
| Clonazepam | Generic | 117 | 19 | $886 |
| Tizanidine Hcl | Generic | 114 | 34 | $3,078 |
| Topiramate | Generic | 110 | 23 | $1,244 |
| Oxcarbazepine | Generic | 95 | 32 | $4,850 |
Hospital affiliations
Frequently asked questions
What is Dr. John Scagnelli's medical specialty?
Dr. John Scagnelli practices Neurology Physician in Raleigh, NC.
Where does Dr. John Scagnelli practice?
Dr. John Scagnelli practices at 1540 Sunday Dr, Raleigh, NC 276076010. Office phone: 9197823456.
What is Dr. John Scagnelli's NPI?
Dr. John Scagnelli's National Provider Identifier (NPI) is 1437268265, issued by NPPES.
Does Dr. John Scagnelli accept Medicare assignment?
Yes. Dr. John Scagnelli accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Scagnelli commonly perform?
Top Medicare-reported procedures in 2023: Injection, natalizumab, 1 mg (HCPCS J2323); Injection, ocrelizumab, 1 mg (HCPCS J2350); Injection, gadobutrol, 0.1 ml (HCPCS A9585). Source: CMS Medicare Physician & Other Practitioners file.